Oral cladribine reshapes CSF immune cell composition in relapsing multiple sclerosis
Cladribine therapy changes immune cells in fluid from the brain in a small MS study
This single-site phase IV clinical trial used single-cell sequencing on CSF and blood from 13 individuals with relapsing MS before and after…
Cladribine therapy reshapes immune cells in the brain's fluid by reducing harmful memory B cells while boosting protective Treg cells in mul…
Cladribine tablets maintain stable patient-reported outcomes in highly active MS over 52 weeks
Your Fitness Tracker Could Now Help Manage Your Multiple Sclerosis
An interim analysis of a prospective observational study in 190 Italian patients with highly active MS found that cladribine tablets maintai…
Multiple sclerosis patients using cladribine tablets maintain physical function while wearables track symptoms continuously between doctor v…